Method described herein provides treatment glaucoma, ocular hypertension and raised intraocular pressure Latanoprost or other therapeutic agents (multiple). The lacrimal point that graft insertion equipment enters patient provides the Latanoprost of sustained release or other therapeutic agents (multiple) are maintained at 7,14,21,30,45,60,90,5 days or more long, avoid patient from not abiding by relevant adverse reaction and mitigate or reduce eye drops application Latanoprost or other therapeutic agents (multiple) and other therapeutic agents (multiple).
